Medtronic reports second quarter fiscal 2023 financial results

Go back to Medtronic reports second quarter fiscal 2023 financial results

Medtronic dips on miss and lower guidance from slow procedure and supply recovery

November 22, 2022 9:01 AM EST

Medtronic (NYSE: MDT) fell nearly 5% in pre-open trading Tuesday following a miss on the top-line for the second quarter and lower full-year guidance.

The medical device maker reported that revenue fell 3% to $7.6 billion, missing the Wall Street consensus of $7.7 billion. The company said the results reflect "slower supply recovery or lower than anticipated underlying market procedure volumes in certain businesses and... More

Medtronic (MDT) Tops Q2 EPS by 2c; Guides FY23 EPS Below the Street

November 22, 2022 6:49 AM EST

Medtronic (NYSE: MDT) reported Q2 EPS of $1.30, $0.02 better than the analyst estimate of $1.28. Revenue for the quarter came in at $7.6 billion versus the consensus estimate of $7.7 billion.

GUIDANCE:

Medtronic sees FY2023 EPS of $5.25-$5.30, versus the consensus of $5.53. The company... More